We investigated whether DPP4i could effectively alleviate the pathogenesis of NASH by regulating hepatic DPP4 expression and lipotoxicity-induced apoptosis using in vivo and in vitro models. Here, DPP4 is linked to metabolic dysfunction-associated steatohepatitis.